Nike (NKE) Exceeds Market Returns: Some Facts to Consider
In the most recent trading session, Nike (NKE) closed at $78.38, indicating a +2.89% shift from the previous trading day.
NIKE vs. Deckers: Which Athletic Footwear Stock Holds More Promise?
DECK builds momentum with HOKA and UGG growth and global expansion, while NKE faces revenue pressure and China weakness.
Nike Defying The Sellside's Bearish Outlook, Eyeing A Breakout Into Earnings
Nike is rebounding with a new CEO, improved tariff clarity, and a focus on core strengths, despite mixed retail sector earnings. Q4 earnings beat expectations, and technical indicators point to a bullish setup, with a potential breakout target near $108 per share. Valuation remains attractive, as shares trade below historical averages, offering about 10% upside to normalized fair value.
NIKE's Classic Franchises Fade: Can Fresh Launches Drive Recovery?
NKE faces a $1B hit from fading classics but bets on fresh launches and sport-led innovation to spark recovery.
NIKE: Patience Will Be Rewarded
Despite near-term EPS headwinds and China/wholesale uncertainty, I reiterate my Buy rating on Nike for long-term investors. Short-term challenges, including tariffs and negative EPS revisions, are likely temporary. Nike's strong ROCE and reinvestment rates support double-digit long-term growth even under my more conservative projections.
NIKE vs. Skechers: Which Player is Ahead in the Global Footwear Race?
NKE emphasizes innovation and cultural scale, while SKX expands globally with comfort and value-driven growth.
Nike (NKE) Stock Declines While Market Improves: Some Information for Investors
Nike (NKE) closed the most recent trading day at $76.39, moving 1.05% from the previous trading session.
“What do you say when somebody says they want to give you $2 billion?” Nike co-founder Phil Knight makes a record donation.
Knight and his wife are making a record private gift to Oregon Health & Science University amid broader battles over public funding for higher education.
Nike co-founder Phil Knight to donate $2 billion to OHSU cancer institute
The Knight Foundation said the gift that will be used to shift the scientific approach to cancer treatment, research and patient care outcomes.
Nike co-founder Phil Knight to donate $2 billion to University of Oregon's Cancer Institute
Nike co-founder Phil Knight is donating $2 billion to the Oregon Health and Science University's Cancer Institute. The Knight Foundation says it's the single largest donation ever to a U.S. university, college or health institution.
Here is What to Know Beyond Why NIKE, Inc. (NKE) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Nike (NKE). This makes it worthwhile to examine what the stock has in store.
NIKE Bets on EMEA Growth: Can This Strategy Pay Off in FY26?
NKE's EMEA strategy drives growth by building on marketplace streamlining and boosting NIKE Digital through an integrated channel approach.
